MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Pro

What Did Legend Biotech's Investor Event Reveal About CARVYKTI

8 hours ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What Did Bunge's 2026 Investor Day Reveal About Its Future

2 months ago

What Do Edesa Biotech's Latest Earnings Reveal About Its Trajectory

2 weeks ago

What Did Skillsoft's Q4 FY2026 Earnings Reveal About Its Trajectory

1 months ago

What Do SSTK's Q1 2026 Results Reveal About Its Core Business

5 days ago

Legend Biotech Conference Spotlights CARVYKTI's Curative Potential, Earlier Use

Legend Biotech highlighted long-term clinical data and physician support for CARVYKTI, its BCMA-directed CAR T-cell therapy for multiple myeloma. The company aims to expand the drug's use into earlier...

LEGN

Stock News•3 days ago

J&J Mastered Cancer Biotech Deals on the Cheap. Can It Stay on the Cutting Edge?

Johnson & Johnson’s reliance on a partnership-heavy biotech strategy has secured cost-effective drug assets, but analysts warn the approach may leave the company exposed to pipeline gaps. The firm now...

JNJ

News•2 weeks ago

The Cancer Test That Wall Street Is Betting On

A diagnostic company has established an early market lead in blood-based cancer recurrence testing. This technology aims to detect returning cancer in survivors, positioning the firm as a potential le...

Stock News•2 weeks ago

Caris Life Sciences, Inc. (CAI) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Caris Life Sciences (CAI) discussed its operational outlook and strategic positioning at the 2026 Bank of America Global Healthcare Conference. The presentation provided insights into the company's cu...

CAI